|
| 37099272 | Correction to: Natural history of spinal cord metastasis from brain glioblastomas. | | 2023 |
| 35953421 | Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: AÂ POLA network study. | Neuro-Oncology | 2023 |
| 36264505 | Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours. | Acta Neuropathol | 2023 |
| 36437415 | Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 |
| 36418240 | Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis. | American Journal of Surgical Pathology | 2023 |
| 36402300 | Molecular and clinical diversity in primary central nervous system lymphoma. | Annals of Oncology | 2023 |
| 36400694 | Challenges in glioblastoma research: focus on the tumor microenvironment. | | 2023 |
| 38009116 | Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM). | | 2023 |
| 37572644 | Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. | | 2023 |
| 37341588 | GluK2 Is a Target for Gene Therapy in Drug-Resistant Temporal Lobe Epilepsy. | | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 37204066 | T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone. | | 2023 |
| 37071666 | Live Stimulated Raman Histology for the Near-Instant Assessment of Central Nervous System Samples. | | 2023 |
| 36997420 | Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023). | Trends Cancer | 2023 |
| 36690453 | Natural Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide Study. | Neurology | 2023 |
| 36991306 | Natural history of spinal cord metastasis from brain glioblastomas. | | 2023 |
| 36918978 | CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm. | Acta Neuropathol Commun | 2023 |
| 36786841 | Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 |
| 37511403 | Deciphering the Action of Neuraminidase in Glioblastoma Models. | | 2023 |
| 34994963 | Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients. | Journal of Neuro-Oncology | 2022 |
| 35522558 | Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study. | Oncologist | 2022 |
| 35836307 | The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases. | Neuropathol Appl Neurobiol | 2022 |
| 35563061 | A2B5 Expression in Central Nervous System and Gliomas. | International Journal of Molecular Sciences | 2022 |
| 36136828 | Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly-A Prospective Study. | Journal of Clinical Endocrinology and Metabolism | 2022 |
| 36428604 | Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank? | Cancers | 2022 |
| 36428602 | Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade -Mutant Gliomas: A French POLA Network Study. | Cancers | 2022 |
| 36315463 | Real-life clinical impact of a five-tiered classification of pituitary tumors. | European Journal of Endocrinology | 2022 |
| 35715818 | MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression. | Biomark Res | 2022 |
| 35598201 | A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused. | Brain Tumor Pathol | 2022 |
| 37284151 | A potential diagnostic pitfall: Primary synovial sarcoma of the central nervous system. | Free Neuropathol | 2022 |
| 34272868 | Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse. | Neuro Oncol | 2022 |
| 34865882 | [The 2021 WHO classification of tumours of the central nervous system]. | Ann Pathol | 2022 |
| 35293634 | Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours. | Neuropathol Appl Neurobiol | 2022 |
| 35259554 | Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy. | Journal of the Neurological Sciences | 2022 |
| 34980260 | Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study. | Acta Neuropathol Commun | 2022 |
| 35239111 | The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients. | J Neurooncol | 2022 |
| 34551121 | Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges. | Neuropathol Appl Neurobiol | 2022 |
| 35118384 | Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma. | Neuro-Oncology Advances | 2022 |
| 34690007 | The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches. | Annals of Oncology | 2021 |
| 34077956 | Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. | Neuro Oncol | 2021 |
| 33803924 | An AI-Powered Blood Test to Detect Cancer Using NanoDSF. | Cancers | 2021 |
| 34056608 | Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. | Neuro-Oncology Advances | 2021 |
| 33783067 | TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. | Oncologist | 2021 |
| 33989642 | Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome. | Neurochirurgie | 2021 |
| 33879448 | Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas. | Cancer Discov | 2021 |
| 33718245 | Specific and Sensitive Diagnosis of <i>BCOR</i>-ITD in Various Cancers by Digital PCR. | Front Oncol | 2021 |
| 33556177 | Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study. | Neuro-Oncology | 2021 |
| 34299200 | Somatotroph Tumors and the Epigenetic Status of the Locus. | International Journal of Molecular Sciences | 2021 |
| 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 |
| 33377141 | Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5. | Neuro Oncol | 2021 |